Amakem NV
๐ง๐ชBelgium
- Country
- ๐ง๐ชBelgium
- Ownership
- Private
- Established
- 2010-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.amakem.com
Multiple Dose-parallel-group Study of AMA0076 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
Phase 2
Completed
- Conditions
- Ocular HypertensionEye DiseaseGlaucoma
- Interventions
- Drug: Placebo
- First Posted Date
- 2014-05-13
- Last Posted Date
- 2015-01-21
- Lead Sponsor
- Amakem, NV
- Target Recruit Count
- 103
- Registration Number
- NCT02136940
- Locations
- ๐บ๐ธ
Artesia Clinical - Site 11, Artesia, California, United States
๐บ๐ธInglewood Clinical Site - Site 15, Inglewood, California, United States
๐บ๐ธPetaluma Clinical Site - Site 17, Petaluma, California, United States
A Single Centre Study to Evaluate 3 Ophthalmic Formulations in Healthy Subjects
Phase 1
Completed
- Conditions
- GlaucomaOcular HypertensionEye Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2013-12-06
- Last Posted Date
- 2014-05-02
- Lead Sponsor
- Amakem, NV
- Target Recruit Count
- 21
- Registration Number
- NCT02003547
Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma
Phase 2
Completed
- Conditions
- GlaucomaOcular HypertensionEye Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2012-09-26
- Last Posted Date
- 2013-07-17
- Lead Sponsor
- Amakem, NV
- Target Recruit Count
- 82
- Registration Number
- NCT01693315
- Locations
- ๐บ๐ธ
Artesia Clinical Site - Site 02, Artesia, California, United States
๐บ๐ธInglewood Clinical Site - Site 03, Inglewood, California, United States
๐บ๐ธPetaluma Clinical Site - Site 05, Petaluma, California, United States